Predictive Factors for a Clinical Diagnosis of Irritable Bowel Syndrome in a Large Cohort of Young Adults.

Overview

The prevalence of IBS in the community has been reported in numerous cross-sectional surveys. However, less is known about the incidence of IBS ,mainly due to its slow development and to patients under-reporting. Furthermore, only one study has analyzed data concerning potential risk factors for the diagnosis of IBS. The investigators will examine the incidence of IBS in a large cohort of young adults and will look at the association of socioeconomic, anthropometric and occupational factors with IBS incidence.

Full Title of Study: “Predictive Factors for a Clinical Diagnosis of Irritable Bowel Syndrome in a Large Cohort of 440,822 Young Adults.”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: May 2013

Arms, Groups and Cohorts

  • irritable bowel syndrome
    • All new cases of clinical diagnosis of irritable bowel syndrome

Clinical Trial Outcome Measures

Primary Measures

  • Incidence of clinical diagnosis of irritable bowel syndrome
    • Time Frame: 6 years
    • New diagnosis of irritable bowel syndrome during this priod

Secondary Measures

  • predictive factors for the clinical diagnosis of irritable bowel syndrome
    • Time Frame: 6 years
    • Anthropometric and demographic factors predictive for the clinicaldiagnosis of irritable bowel syndrome including gender, body mass index, ethnicity , type of service

Participating in This Clinical Trial

Inclusion Criteria

  • All Israeli men and women – aged 18-39 years – served in active military service (mandatory and career service) between the years 2005-2011 Exclusion Criteria:

  • Diagnosis of celiac disease – Inflammatory bowel disease – Cancer in the digestive system

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 39 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Medical Corps, Israel Defense Force
  • Provider of Information About this Clinical Study
    • Principal Investigator: DAN CARTER, Head of Gastro Service – Medical Corps, Israel Defense Force

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.